BMO Capital Maintains Outperform on Aveanna Healthcare Hldgs, Lowers Price Target to $10

Benzinga Newsdesk www.benzinga.com Negative 94.6%

Neg 94.6% Neu 0% Pos 0%

BMO Capital analyst Sean Dodge maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Outperform and lowers the price target from $11 to $10.